文献速递腹部泌尿生殖MR

基于压缩感知的三维磁共振胰胆管成像临床可行性:图像质量与诊断性能比较

Clinical Feasibility of 3-Dimensional Magnetic Resonance Cholangiopancreatography Using Compressed Sensing: Comparison of Image Quality and Diagnostic Performance.
PubMed 文献 · Invest Radiol · 2017-01-01

回顾性纳入84例患者,比较传统导航触发3D-MRCP与压缩感知3D-MRCP,其中28例加做屏气CS-MRCP。CS-MRCP采集时间缩短至227.0秒,屏气CS-MRCP仅16秒,图像清晰度和胆胰管显示更优但背景抑制较低,整体图像质量无显著差异。

要点

  • CS-MRCP胆总管和胰管显示评分优于传统MRCP,但背景抑制较低。
  • 屏气CS-MRCP图像质量优于传统MRCP和CS-MRCP,采集时间仅16秒。
  • CS-MRCP对胆管解剖变异及病变的不确定检查比例较传统MRCP降低。

核心结论

  • 采用非相干欠采样结合CS重建的压缩感知MRCP可提供与传统MRCP相当的图像质量,同时将采集时间缩短至单次屏气内(16秒)。

研究设计与样本

  • 回顾性研究,纳入84例患者(男41例、女43例,平均年龄47.3±18.8岁),在3 T扫描仪上行传统导航触发T2加权SPACE MRCP和CS SPACE MRCP,其中28例另加行3D屏气CS-MRCP(k空间采样率5.7%)。

关键影像表现/征象

  • CS-MRCP图像清晰度评分3.54±0.60优于传统MRCP的3.37±0.75(P=0.04)。
  • CS-MRCP胆总管显示评分4.55±0.60优于传统MRCP的4.39±0.78(P=0.034)。
  • CS-MRCP胰管显示评分3.47±1.22优于传统MRCP的3.26±1.32(P=0.025)。
  • CS-MRCP背景抑制评分3.00±0.54低于传统MRCP的3.37±0.58(P<0.001)。
  • CS-MRCP与传统MRCP整体图像质量评分分别为3.51±0.95与3.47±1.09,差异无统计学意义(P=0.75)。

诊断标准与关键数值

  • 图像质量采用5分制评分(胆管和胰管显示、整体图像质量),评分越高图像质量越好。
  • 图像清晰度和背景抑制采用4分制评分,评分越高图像质量越好。
  • BH-CS-MRCP检测胆管疾病的敏感度为88.9%至100%,传统MRCP亦为88.9%至100%(P>0.05)。
  • BH-CS-MRCP检测胰腺疾病的敏感度为66.7%至83.3%,传统MRCP为50.0%至72.2%(读者1 P=0.002,读者2-3 P=0.06-0.47)。

临床应用与阅片要点

  • CS-MRCP可缩短采集时间至227.0秒,屏气CS-MRCP仅需16秒,便于不能长时间屏气的患者检查。
  • CS-MRCP背景抑制较低,阅片时需注意与图像清晰度及胆胰管显示之间的权衡。
  • CS-MRCP减少了胆管解剖变异及病变的不确定检查比例,从16.7%-22.6%降至9.5%-11.9%,从8.4%-15.6%降至3.6%-8.4%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The aim of this study was to evaluate the clinical feasibility of fast 3-dimensional (3D) magnetic resonance cholangiopancreatography (MRCP) using compressed sensing (CS) in comparison with conventional navigator-triggered 3D-MRCP.

MATERIALS AND METHODS: This retrospective study was approved by our institutional review board, and the requirement of informed consent was waived. A total of 84 patients (male-to-female ratio, 41:43; mean age, 47.3 ± 18.8 years) who underwent conventional 3D navigator-triggered T2-weighted MRCP using sampling perfection with application optimized contrasts (SPACE) and fast 3D MRCP using SPACE with high undersampling combined with CS reconstruction (CS SPACE; CS-MRCP) on a 3 T scanner were included. Among them, 28 patients additionally underwent 3D breath-hold CS-MRCP (BH-CS-MRCP) with 5.7% k-space sampling. Three board-certified radiologists then independently reviewed the examinations for bile duct and pancreatic duct visualization and overall image quality on a 5-point scale, and image sharpness and background suppression on a 4-point scale, with the higher score indicating better image quality. In addition, diagnostic performance for the detection of anatomic variation and diseases of the bile duct, and pancreatic disease were assessed on a per-patient basis in the subgroup of 28 patients who underwent conventional MRCP, CS-MRCP, and BH-CS-MRCP in the same manner.

RESULTS: Mean acquisition times of conventional MRCP, CS-MRCP, and BH-CS-MRCP were 7 minutes (419.7 seconds), 3 minutes 47 seconds (227.0 seconds), and 16 seconds, respectively (P < 0.0001, in all comparisons). In all patients, CS-MRCP showed better image sharpness (3.54 ± 0.60 vs 3.37 ± 0.75, P = 0.04) and visualization of the common bile duct (4.55 ± 0.60 vs 4.39 ± 0.78, P = 0.034) and pancreatic duct (3.47 ± 1.22 vs 3.26 ± 1.32, P = 0.025), but lower background suppression (3.00 ± 0.54 vs 3.37 ± 0.58, P < 0.001) than conventional MRCP. Overall image quality was not significantly different between the 2 examinations (3.51 ± 0.95 vs 3.47 ± 1.09, P = 0.75). The number of indeterminate MRCP examinations for the anatomic variation and disease of the bile duct significantly decreased on CS-MRCP, from 16.7%-22.6% to 9.5%-11.9% and 8.4%-15.6% to 3.6%-8.4% in all readers (P = 0.003-0.03). In the 28 patients who underwent BH-CS-MRCP, better image quality was demonstrated than with conventional MRCP and CS-MRCP (4.10 ± 0.84 vs 3.44 ± 1.21 vs 3.50 ± 1.11, respectively, P = 0.002, 0.001). Sensitivities for detecting bile duct disease was 88.9% to 100% on both BH-CS-MRCP and conventional MRCP (P > 0.05), and for detecting pancreatic disease was 66.7% to 83.3% on BH-CS-MRCP and 50.0% to 72.2% on conventional MRCP (P = 0.002 in reader 1, 0.06-0.47 in readers 2-3).

CONCLUSIONS: Compressed sensing MRCP using incoherent undersampling combined with CS reconstruction provided comparable image quality to conventional MRCP while reducing the acquisition time to within a single breath-hold (16 seconds).

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Yoon JH, Lee SM, Kang HJ, et al. Clinical Feasibility of 3-Dimensional Magnetic Resonance Cholangiopancreatography Using Compressed Sensing: Comparison of Image Quality and Diagnostic Performance. Invest Radiol. 2017. PMID: 28448309. doi:10.1097/RLI.0000000000000380

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。